DATASEA INC (DTSS)

US2381163052 - Common Stock

8.19  +0.39 (+5%)

After market: 8.18 -0.01 (-0.12%)

Fundamental Rating

1

Overall DTSS gets a fundamental rating of 1 out of 10. We evaluated DTSS against 276 industry peers in the Software industry. Both the profitability and financial health of DTSS have multiple concerns. DTSS is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

DTSS had negative earnings in the past year.
In the past year DTSS has reported a negative cash flow from operations.
In the past 5 years DTSS always reported negative net income.
DTSS had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

DTSS has a Return On Assets of -176.21%. This is amonst the worse of the industry: DTSS underperforms 92.70% of its industry peers.
DTSS has a Return On Equity of -334.79%. This is amonst the worse of the industry: DTSS underperforms 85.77% of its industry peers.
Industry RankSector Rank
ROA -176.21%
ROE -334.79%
ROIC N/A
ROA(3y)-212.45%
ROA(5y)-138.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 1.32%, DTSS is doing worse than 88.32% of the companies in the same industry.
In the last couple of years the Gross Margin of DTSS has declined.
DTSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-62.31%
GM growth 5Y-45.47%

2

2. Health

2.1 Basic Checks

DTSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DTSS has more shares outstanding
The number of shares outstanding for DTSS has been increased compared to 5 years ago.
DTSS has a worse debt/assets ratio than last year.

2.2 Solvency

DTSS has an Altman-Z score of -4.55. This is a bad value and indicates that DTSS is not financially healthy and even has some risk of bankruptcy.
DTSS's Altman-Z score of -4.55 is on the low side compared to the rest of the industry. DTSS is outperformed by 82.85% of its industry peers.
DTSS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DTSS (0.00) is better than 71.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.55
ROIC/WACCN/A
WACC8.17%

2.3 Liquidity

DTSS has a Current Ratio of 1.68. This is a normal value and indicates that DTSS is financially healthy and should not expect problems in meeting its short term obligations.
DTSS has a Current ratio (1.68) which is comparable to the rest of the industry.
DTSS has a Quick Ratio of 1.61. This is a normal value and indicates that DTSS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.61, DTSS is in line with its industry, outperforming 48.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.61

3

3. Growth

3.1 Past

DTSS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -309.23%.
Looking at the last year, DTSS shows a very strong growth in Revenue. The Revenue has grown by 201.38%.
The Revenue has been growing by 271.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-309.23%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1344.32%
Revenue 1Y (TTM)201.38%
Revenue growth 3Y71%
Revenue growth 5Y271.23%
Revenue growth Q2Q2539.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DTSS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DTSS!.
Industry RankSector Rank
Dividend Yield N/A

DATASEA INC

NASDAQ:DTSS (4/26/2024, 7:00:02 PM)

After market: 8.18 -0.01 (-0.12%)

8.19

+0.39 (+5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.80M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -176.21%
ROE -334.79%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 1.32%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover4.79
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.68
Quick Ratio 1.61
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-309.23%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)201.38%
Revenue growth 3Y71%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y